An interventional study of cognitive training and control group in Cognitive Dysfunction, sponsored by Charite University, Berlin, Germany. Status unknown at 1 site in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2009-11-13.
Sponsored by Charite University, Berlin, Germany · Not applicable, Interventional, and Treatment
The purpose of this study is to improve cognitive dysfunction following chemotherapy, the investigators investigated to see whether a cognitive training for memory and concentration skills can improve cognitive performance in patients following cancer treatment.
Patients following chemotherapy invited for a cognitive training. Before and after cognitive function will evaluate.
3,843 studies on the registry are indexed under Cognitive Dysfunction; 1,100 are open to participants now.
This study's planned enrollment of 20 is below the median of 65 across 2,808 interventional studies indexed under Cognitive Dysfunction.
Browse Cognitive Dysfunction studies →Charite University, Berlin, Germany is the lead sponsor of 836 studies on the registry; 129 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Patients in this group start the cognitive training over 6 weeks directly after randomization.
Behavioral: cognitive training
In this control group begin the training in a cross-over design 7 weeks after randomization.
Other: control group
cognitive training over 6 weeks, consist of 6 meetings (a 45minutes), three sessions focus on concentration tasks and three sessions on memory problems.
Also known as: training group
no intervention
Also known as: controll group
several cognitive tests (TAP, VLMT, TMT, Stroop, RWT, D2, LGT-3)
Time frame: one weeks following the end of the cognitive training
quality of life and subjective perception of cognitive problems
Time frame: 7 weeks
This study is status unknown, as verified in Nov 2009. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Charite University, Berlin, Germany